tiprankstipranks
Immunome, Inc. (IMNM)
NASDAQ:IMNM
US Market
IMNM
Immunome
RESEARCH TOOLSreports

Immunome (IMNM) Stock News & Sentiment

437 Followers
Immunome: Best-in-Class Varegacestat Data and Deep ADC Pipeline Support Buy Rating and Favorable Risk‑Reward
Premium
Ratings
Immunome: Best-in-Class Varegacestat Data and Deep ADC Pipeline Support Buy Rating and Favorable Risk‑Reward
28d ago
IMNM
Immunome: Buy Rating on Best-in-Class Varegacestat Opportunity and Differentiated Next-Generation ADC Oncology Platform
Premium
Ratings
Immunome: Buy Rating on Best-in-Class Varegacestat Opportunity and Differentiated Next-Generation ADC Oncology Platform
1M ago
IMNM
Immunome: Advancing Best-in-Class Varegacestat and a Data-Driven ADC Pipeline Support Buy Rating and $40 Target
Premium
Ratings
Immunome: Advancing Best-in-Class Varegacestat and a Data-Driven ADC Pipeline Support Buy Rating and $40 Target
2M ago
IMNM
Immunome: Differentiated Oncology Portfolio and ADC Platform Underpin Buy Rating and $40 Price Target
Premium
Ratings
Immunome: Differentiated Oncology Portfolio and ADC Platform Underpin Buy Rating and $40 Price Target
2M ago
IMNM
Immunome Announces Follow-On Public Offering Pricing
Premium
Company Announcements
Immunome Announces Follow-On Public Offering Pricing
4M ago
8K
IMNM
3 ‘Strong Buy’ Biotech Stocks to Buy Now, According to Top Analysts
Premium
Market News
3 ‘Strong Buy’ Biotech Stocks to Buy Now, According to Top Analysts
4M ago
IMNM
KYTX
Immunome’s Promising Outlook: Buy Rating Affirmed on Varegacestat’s Phase 3 Success and Strong Management
Premium
Ratings
Immunome’s Promising Outlook: Buy Rating Affirmed on Varegacestat’s Phase 3 Success and Strong Management
4M ago
IMNM
More IMNM News >

IMNM News on the Web

Leerink says Tubulis deal highlights value of ADC platforms like Sutro’s
TipRanks News
Neutral
Immunome (IMNM) Receives a Buy from LifeSci Capital
TipRanks News
Neutral
Immunome's Chief Scientist Trimmed His Stake. A Planned FDA Submission Tells You More
The Motley Fool
Bullish
Immunome (IMNM) Moves 13.3% Higher: Will This Strength Last?
Zacks
Bullish
Top Biotech Boss Makes Bold Insider Move on Immunome Shares
TipRanks News
Neutral
Insider Buying: Clay Siegall Acquires Shares of Immunome Inc (IMNM)
GuruFocus News
Neutral
Why Immunome’s Stock Is Suddenly Surging Higher
TipRanks News
Bullish
Why Immunome Stock Is Suddenly Racing Higher
TipRanks News
Bullish

News Score - Last 7 Days

Neutral
IMNM
Sector Average
Media Buzz
This Week3 articles
Weekly Average3 articles
News Sentiment
This Week100%
Sector Average66%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is IMNM’s Media Buzz Sentiment?
3 articles about IMNM were published this week. In an average week, 3 articles are published.
    What is IMNM’s weekly average amount of articles?
    In an average week, 3 articles about IMNM are published.
      What is IMNM’s News Sentiment?
      100% of articles about IMNM were positive this week, compared to its sector average of 66%.
        Healthcare Stocks that are Trending in the News
        VCELVericel
        NBIXNeurocrine
        ANGOAngioDynamics
        ORGOOrganogenesis Holdings
        UNHUnitedHealth Group Incorporated Shs -CAD hedged- Canadian Depositary Receipt Repr Shs Reg S
        Showing the stocks with the most bullish news sentiment over the past week